Evidence map›Paper›PMID 24218168›Full record

ArticleFish physiology and biochemistry2014

Histopathological and estrogen effect of pentachlorophenol on the rare minnow (Gobiocypris rarus).

Xiaozheng Zhang, Li Xiong, Yan Liu, Chuan Deng, Siyu Mao

Abstract read
PubMed Publisher
In one paragraph

Article in Fish physiology and biochemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xiaozheng ZhangKey Laboratory of Freshwater Fish Reproduction and Development, Key Laboratory of Eco-environments in Three Gorges Reservoir Region, Key Laboratory of Aquatic Science of Chongqing, School of Life Science, Southwest University, Chongqing, 400715, China.
Li Xiong
Yan Liu
Chuan Deng
Siyu Mao
Southwest University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pentachlorophenol (PCP), a typical organic pollutant and environmental endocrine disruptor, has been extensively used as a pesticide and biocide worldwide. In this study, the effects of PCP on the histological and hepatic system of the rare minnow (Gobiocypris rarus) were evaluated. Vitellogenin (VTG) was used as a biomarker to evaluate the estrogen effect of PCP. The results revealed that VTG was highly expressed and PCP exposure had histopathological effects on the rare minnow. Plasma and hepatic VTG concentrations increased when female rare minnows were exposed to ≥80 μg/L PCP and male rare minnows were exposed to 40 μg/L PCP (p < 0.05), which suggested that the VTG expression was evoked by PCP exposure. The results indicated that both plasma and liver tissue were suitable for VTG quantification. A significant decrease in the mRNA level of hepatic estrogen receptor-α (ERα) in male or juvenile was observed after exposure to ≥80 or ≥8 μg/L PCP, respectively; in contrast, increased mRNA levels of ERβ1, ERβ2, VTGI, and VTGII in male or juvenile were detected after exposure to ≥80 or ≥8 μg/L PCP, respectively. These results suggested that PCP has an estrogen effect and exists within different endocrine-disrupting pathways from other environmental contaminants. As such, VTG mRNA expression in the rare minnow may require transcription of the ERβ1 and ERβ2 genes.

Indexed as

AnimalsCyprinidaeEndocrine DisruptorsFemaleFish ProteinsImmunohistochemistryLiverMaleModels, AnimalPentachlorophenolReceptors, EstrogenVitellogeninsEndocrine DisruptorsFish ProteinsPentachlorophenolReceptors, EstrogenVitellogenins

Identifiers

PMID24218168
OpenAlexW2094416633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.